Story Navigation
-
DiscoveryNovartis Institutes for BioMedical ResearchRare DiseasesClinical ResearchCareersBiomedical JobsGene TestingGenetic Disease
Novartis researches SMA’s genetic roots
Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
Discovery -
Access to HealthcareDisease EradicationGlobal Health PartnershipsMalariaNovartis Social BusinessPatient EducationTropical Diseases
New drugs could offer hope for malaria patients
In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.
Access to Healthcare -
DiscoveryNovartis Institutes for BioMedical Research
Novartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Discovery -
DiscoveryNovartis Institutes for BioMedical Research
Mutant protein spreads through a neural circuit in Huntington’s Disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Discovery -
Patient PerspectivesFuture of HealthcareMedical InnovationsNeurodegenerative Disease
Longevity with vitality: Japanese elders provide examples for healthy aging
Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging.
Patient Perspectives -
DiscoveryNovartis Institutes for BioMedical ResearchTargeted Therapy
Cancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
CancerFuture of HealthcareInnovation
Combination therapies: Seeking to block cancer’s pathways to growth
Talk to any cancer researcher or doctor today and what you hear is wonder and hope.
-
DiscoveryNovartis Institutes for BioMedical Research
Cancer cocktails: LEE011 – a popular combination partner
Discovery -
Novartis Institutes for BioMedical Research
Cancer cocktails: LJM716 – closing a common release valve
-
DiscoveryNovartis Institutes for BioMedical Research
Cancer cocktails: ABL001 – hitting one target twice
Discovery -
From Our LabsAccess to HealthcareDigitalEmerging TechnologyMobile Devices
mHealth: A revolution in healthcare
Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
From Our Labs -
Patient PerspectivesDisease AwarenessLiving With DiseasePatient Education
Experts call for new approach to patient and physician management of type 2 diabetes
A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.
Patient Perspectives
Pagination
- ‹ Previous page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- › Next page